Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022

Patients with early-stage nasopharyngeal cancer are treated with definitive radiotherapy alone, including both sides of the neck and retropharyngeal nodes. For patients with locoregionally advanced nasopharyngeal cancer, the recommendation is concurrent chemoradiotherapy with additional chemotherapy...

Full description

Saved in:
Bibliographic Details
Published inCancer research, statistics, and treatment (Online) Vol. 7; no. Suppl 1; pp. S27 - S30
Main Authors Gairola, Munish, Prabhash, Kumar, Babu, K Govind, Chaturvedi, Pankaj, Kuriakose, Moni, Birur, Praveen, Anand, Anil K., Kaushal, Ashish, Mahajan, Abhishek, Syiemlieh, Judita, Singhal, Manish, Ramachandra, Prakash, Goyal, Sumit, John, Subashini, Nayyar, Rohit, Patil, Vijay M., Rao, Vishal, Noronha, Vanita, Roshan, Vikas, Rath, G.K.
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer - Medknow 01.01.2024
Edition2
Subjects
Special Article
Indian guidelines
nasopharyngeal cancer
chemotherapy
recommendations
Chemoradiation
Online AccessGet full text
ISSN2590-3233
2590-3225
DOI10.4103/crst.crst_123_23

Cover

Abstract Patients with early-stage nasopharyngeal cancer are treated with definitive radiotherapy alone, including both sides of the neck and retropharyngeal nodes. For patients with locoregionally advanced nasopharyngeal cancer, the recommendation is concurrent chemoradiotherapy with additional chemotherapy (either before or after chemoradiotherapy). Adding targeted therapies like nimotuzumab to concurrent chemoradiation in the management of nasopharyngeal cancer has been shown to improve overall survival with excellent safety and tolerability.
AbstractList Patients with early-stage nasopharyngeal cancer are treated with definitive radiotherapy alone, including both sides of the neck and retropharyngeal nodes. For patients with locoregionally advanced nasopharyngeal cancer, the recommendation is concurrent chemoradiotherapy with additional chemotherapy (either before or after chemoradiotherapy). Adding targeted therapies like nimotuzumab to concurrent chemoradiation in the management of nasopharyngeal cancer has been shown to improve overall survival with excellent safety and tolerability.
Author Goyal, Sumit
Noronha, Vanita
John, Subashini
Ramachandra, Prakash
Birur, Praveen
Syiemlieh, Judita
Chaturvedi, Pankaj
Mahajan, Abhishek
Roshan, Vikas
Babu, K Govind
Patil, Vijay M.
Gairola, Munish
Anand, Anil K.
Prabhash, Kumar
Singhal, Manish
Kaushal, Ashish
Rath, G.K.
Kuriakose, Moni
Nayyar, Rohit
Rao, Vishal
Author_xml – sequence: 1
  givenname: Munish
  surname: Gairola
  fullname: Gairola, Munish
– sequence: 2
  givenname: Kumar
  surname: Prabhash
  fullname: Prabhash, Kumar
– sequence: 3
  givenname: K Govind
  surname: Babu
  fullname: Babu, K Govind
– sequence: 4
  givenname: Pankaj
  surname: Chaturvedi
  fullname: Chaturvedi, Pankaj
– sequence: 5
  givenname: Moni
  surname: Kuriakose
  fullname: Kuriakose, Moni
– sequence: 6
  givenname: Praveen
  surname: Birur
  fullname: Birur, Praveen
– sequence: 7
  givenname: Anil K.
  surname: Anand
  fullname: Anand, Anil K.
– sequence: 8
  givenname: Ashish
  surname: Kaushal
  fullname: Kaushal, Ashish
– sequence: 9
  givenname: Abhishek
  surname: Mahajan
  fullname: Mahajan, Abhishek
– sequence: 10
  givenname: Judita
  surname: Syiemlieh
  fullname: Syiemlieh, Judita
– sequence: 11
  givenname: Manish
  surname: Singhal
  fullname: Singhal, Manish
– sequence: 12
  givenname: Prakash
  surname: Ramachandra
  fullname: Ramachandra, Prakash
– sequence: 13
  givenname: Sumit
  surname: Goyal
  fullname: Goyal, Sumit
– sequence: 14
  givenname: Subashini
  surname: John
  fullname: John, Subashini
– sequence: 15
  givenname: Rohit
  surname: Nayyar
  fullname: Nayyar, Rohit
– sequence: 16
  givenname: Vijay M.
  surname: Patil
  fullname: Patil, Vijay M.
– sequence: 17
  givenname: Vishal
  surname: Rao
  fullname: Rao, Vishal
– sequence: 18
  givenname: Vanita
  surname: Noronha
  fullname: Noronha, Vanita
– sequence: 19
  givenname: Vikas
  surname: Roshan
  fullname: Roshan, Vikas
– sequence: 20
  givenname: G.K.
  surname: Rath
  fullname: Rath, G.K.
BookMark eNp9kEtLAzEQgINUsNbePeYPtGaTTbfrTYqPQsGD9hxmk9k2dDdZkpTiv3drVUTQyzyY-YbhuyQD5x0Scp2xaZ4xcaNDTNNjUBkXioszMuSyZBPBuRx810JckHGMtmJ5XgguhRySeumMBUd1Y53V0NAugE5WI9XeRXRxH-lmbw32c4y09oGmLdIWHGywRZeor6mD6LsthDe3wf6EBqcx3NJ1ZyAh5YzzK3JeQxNx_JlHZP1w_7p4mqyeH5eLu9VEZ-WsmRjIIBeyrOVMZxUUeTlnTEjJWaXFnJfc1JnJeWUKnPcLJUoG0PeIlTSlLsWIsNNdHXyMAWvVBdv2n6mMqaMq9WHph6oemf1CtE2QrHcpgG3-A5cn8OCbhCHumv0Bg2rR7Jw__MmpF16ok3X1ZV28A1UVkBY
CitedBy_id crossref_primary_10_4103_crst_crst_118_23
Cites_doi 10.1200/JCO.2017.35.15_suppl.6006
10.1016/j.oraloncology.2015.11.019
10.1016/S1470-2045(16)30410-7
10.2147/OTT.S141538
10.1056/NEJMoa1905287
10.3389/fonc.2019.00464
10.1001/jamaoncol.2022.0122
10.1371/journal.pone.0153498
10.4103/ijc.IJC_287_17
10.3389/fonc.2018.00597
10.1016/S1470-2045(15)70126-9
10.1002/cncr.29208
10.1016/S1470-2045(11)70320-5
10.1200/JCO.2016.67.4119
10.4103/2278-330x.214578
10.1007/s12105-014-0528-6
10.1016/j.tranon.2017.11.002
10.3389/fonc.2020.585046
ContentType Journal Article
Copyright Copyright: © 2024 Cancer Research, Statistics, and Treatment
Copyright_xml – notice: Copyright: © 2024 Cancer Research, Statistics, and Treatment
DBID AAYXX
CITATION
DOI 10.4103/crst.crst_123_23
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2590-3225
Edition 2
EndPage S30
ExternalDocumentID 10_4103_crst_crst_123_23
CRSAT-7-S27
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
GROUPED_DOAJ
OK1
OVD
RMW
TEORI
W3E
AAYXX
ADJBI
CITATION
ID FETCH-LOGICAL-c196l-da1a4359f56c1ba74980035520bc38292df1d42bd7e8c1b9e50aa42beeb5d9c93
IEDL.DBID W3E
ISSN 2590-3233
IngestDate Tue Jul 01 03:54:05 EDT 2025
Thu Apr 24 22:59:50 EDT 2025
Wed May 28 23:14:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 1
Keywords Indian guidelines
nasopharyngeal cancer
chemotherapy
recommendations
Chemoradiation
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c196l-da1a4359f56c1ba74980035520bc38292df1d42bd7e8c1b9e50aa42beeb5d9c93
OpenAccessLink https://doi.org/10.4103/crst.crst_123_23
ParticipantIDs crossref_primary_10_4103_crst_crst_123_23
crossref_citationtrail_10_4103_crst_crst_123_23
wolterskluwer_medknow_10_4103_crst_crst_123_23_S27_Indian_clinical
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240100
2024-01-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 20240100
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Cancer research, statistics, and treatment (Online)
PublicationYear 2024
Publisher Wolters Kluwer - Medknow
Publisher_xml – name: Wolters Kluwer - Medknow
References Li (R20-20240828) 2022; 8
Liu (R16-20240828) 2018; 8
Haleshappa (R9-20240828) 2017; 6
Ribassin-Majed (R8-20240828) 2017; 35
Lee (R18-20240828) 2015; 121
Li (R4-20240828) 2017; 10
Kunheri (R5-20240828) 2017; 54
Chen (R6-20240828) 2012; 13
Zhang (R19-20240828) 2019; 381
Szturz (R15-20240828) 2019; 9
Lewis (R1-20240828) 2014; 8
R3-20240828
Sun (R11-20240828) 2022; 40
Blanchard (R10-20240828) 2015; 16
Banko (R2-20240828) 2016; 11
Su (R13-20240828) 2021; 10
Sun (R17-20240828) 2016; 17
Ahn (R14-20240828) 2016; 53
Yuan (R12-20240828) 2017; 22
Wang (R21-20240828) 2018; 11
Liang (R7-20240828) 2017; 35
References_xml – volume: 35
  start-page: 6006.
  year: 2017
  ident: R7-20240828
  article-title: Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicenter randomized controlled trial (ChiCTR-TRC-12001979)
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.35.15_suppl.6006
– volume: 22
  start-page: 1004
  year: 2017
  ident: R12-20240828
  article-title: Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis
  publication-title: J BUON
– volume: 53
  start-page: 10
  year: 2016
  ident: R14-20240828
  article-title: Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2015.11.019
– volume: 17
  start-page: 1509
  year: 2016
  ident: R17-20240828
  article-title: Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomized controlled trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(16)30410-7
– volume: 10
  start-page: 5445
  year: 2017
  ident: R4-20240828
  article-title: Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S141538
– volume: 381
  start-page: 1124
  year: 2019
  ident: R19-20240828
  article-title: Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1905287
– ident: R3-20240828
  article-title: Guideline Version 2.2019
  publication-title: Head and neck cancers
– volume: 9
  start-page: 464.
  year: 2019
  ident: R15-20240828
  article-title: Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer: Recommendations for clinical practice
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.00464
– volume: 8
  start-page: 706
  year: 2022
  ident: R20-20240828
  article-title: Effect of induction chemotherapy with paclitaxel, cisplatin, and capecitabine vs cisplatin and fluorouracil on failure-free survival for patients with stage IVA to IVB nasopharyngeal carcinoma a multicenter phase 3 randomized clinical trial
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2022.0122
– volume: 11
  start-page: e0153498.
  year: 2016
  ident: R2-20240828
  article-title: Characterization of the variability of Epstein-Barr virus genes in nasopharyngeal biopsies: Potential predictors for carcinoma progression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0153498
– volume: 54
  start-page: 502
  year: 2017
  ident: R5-20240828
  article-title: Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India
  publication-title: Indian J Cancer
  doi: 10.4103/ijc.IJC_287_17
– volume: 8
  start-page: 597.
  year: 2018
  ident: R16-20240828
  article-title: The changing role of chemotherapy in locoregionally advanced nasopharyngeal carcinoma: An updated systemic review and network meta-analysis
  publication-title: Front Oncol
  doi: 10.3389/fonc.2018.00597
– volume: 16
  start-page: 645
  year: 2015
  ident: R10-20240828
  article-title: Chemotherapy and radiotherapy in nasopharyngeal carcinoma: An update of the MAC-NPC meta-analysis
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)70126-9
– volume: 121
  start-page: 1328
  year: 2015
  ident: R18-20240828
  article-title: Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
  publication-title: Cancer
  doi: 10.1002/cncr.29208
– volume: 13
  start-page: 163
  year: 2012
  ident: R6-20240828
  article-title: Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicenter randomized controlled trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(11)70320-5
– volume: 35
  start-page: 498
  year: 2017
  ident: R8-20240828
  article-title: What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.67.4119
– volume: 40
  issue: suppl 6001
  year: 2022
  ident: R11-20240828
  article-title: Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial
  publication-title: J Clin Oncol
– volume: 6
  start-page: 122
  year: 2017
  ident: R9-20240828
  article-title: Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India
  publication-title: South Asian J Cancer
  doi: 10.4103/2278-330x.214578
– volume: 8
  start-page: 50
  year: 2014
  ident: R1-20240828
  article-title: Human papilloma virus and Epstein Barr virus in head and neck carcinomas: Suggestions for the new WHO classification
  publication-title: Head Neck Pathol
  doi: 10.1007/s12105-014-0528-6
– volume: 11
  start-page: 65
  year: 2018
  ident: R21-20240828
  article-title: Treatment outcomes of 257 patients with locoregionally advanced nasopharyngeal carcinoma treated with nimotuzumab plus intensity-modulated radiotherapy with or without chemotherapy: A single-institution experience
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2017.11.002
– volume: 10
  start-page: 585046.
  year: 2021
  ident: R13-20240828
  article-title: The current role of adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.585046
SSID ssib044732535
ssj0002511772
ssib053799620
Score 2.2466002
Snippet Patients with early-stage nasopharyngeal cancer are treated with definitive radiotherapy alone, including both sides of the neck and retropharyngeal nodes. For...
SourceID crossref
wolterskluwer
SourceType Enrichment Source
Index Database
Publisher
StartPage S27
SubjectTerms Special Article
Title Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022
URI https://doi.org/10.4103/crst.crst_123_23
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8QwFA4uIIKIK44bOXjxUKfN0rTeVEZEGC866C0kaepBpzPMgnjxt_tel3EE9eQlUEha-PKa9-WthJxkxmapdSpQhsEFBU1WiZQ8yCXzMY-slWUlpu5dfNMTt0_yqbZ3YC7MnP9eRCFvO-BAZzhoOGI144tkmakoRfl95J1GcoRQnMkvxS-5Ah5fEyE8k5FIq7KTE9B9OHgY55XP8sePfNNRa28D9FuPX8qw9Tnlc71B1mvWSC-qbd4kC77YIivd2i--TbADB-wzbfIcaZP8RB1GSxfj6Zg-T7GiFUa5UyCqFIgf7c9iX-ggp4XBlgZm9F48A3ukDuVhdE57QzQKUAZqeIf0rjsPVzdB3UEhcPBnvQaZiQzwoTSXsYusUSJN0HUoWWgdT1jKsjzKBLOZ8glMSL0MjYFn763MUpfyXbJUDAq_RygQP56EluW5MMLa0GAvBOkNE3FulVct0m4w064uL45dLl41XDMQZV0CPIdyi5zOVgyr0hp_zL38tg26XyUL_rpA3zOlK-x1g_3-f7zkgKwC4KKywhySpclo6o-Al0zscXmfh7H70TkuxfMThFzkzA
linkProvider Wolters Kluwer Health
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indian+clinical+practice+consensus+guidelines+for+the+management+of+nasopharyngeal+cancer%3A+Update+2022&rft.jtitle=Cancer+research%2C+statistics%2C+and+treatment+%28Online%29&rft.au=Gairola%2C+Munish&rft.au=Prabhash%2C+Kumar&rft.au=Babu%2C+K+Govind&rft.au=Chaturvedi%2C+Pankaj&rft.date=2024-01-01&rft.issn=2590-3233&rft.eissn=2590-3225&rft.volume=7&rft.issue=Suppl+1&rft.spage=S27&rft.epage=S30&rft_id=info:doi/10.4103%2Fcrst.crst_123_23&rft.externalDBID=n%2Fa&rft.externalDocID=10_4103_crst_crst_123_23
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-3233&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-3233&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-3233&client=summon